Two Treatments Show Benefits in Juvenile Myasthenia Gravis

(MedPage Today) — SAN FRANCISCO — Two studies demonstrated the benefits of treating juvenile myasthenia gravis (MG) with newer drugs.
Interim results from the phase II/III ADAPT Jr study showed that efgartigimod (Vyvgart), a drug approved…

Source link : https://www.medpagetoday.com/meetingcoverage/aanem/118275

Author :

Publish date : 2025-11-03 16:22:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Two Treatments Show Benefits in Juvenile Myasthenia Gravis

The anthropologist shaking up the way we name human species

Walking 3000 steps a day seems to slow Alzheimer’s-related decline

Related Posts

Resident doctors in Scotland to go on strike for first time

Proton Therapy for Oropharyngeal Cancer Makes a Case for Standard of Care

Lyme Created in a Lab? ‘Wild Pregnancies’; Diabetes Program Flopped

Issue of Healthcare Rises Sharply as Americans’ Priority for Government to Address

CDC Gives Danish Researchers $1.6M to Study Hep B Vaccine Birth Dose in Africa

Light Therapy for Dry AMD: What Do We Know?

Resident doctors in Scotland to go on strike for first time

Proton Therapy for Oropharyngeal Cancer Makes a Case for Standard of Care

Lyme Created in a Lab? ‘Wild Pregnancies’; Diabetes Program Flopped

Issue of Healthcare Rises Sharply as Americans’ Priority for Government to Address

CDC Gives Danish Researchers $1.6M to Study Hep B Vaccine Birth Dose in Africa

Light Therapy for Dry AMD: What Do We Know?

Putting data centres in space isn’t going to happen any time soon

Deaths Prompt Clinical Trial Hold; $8,000 Scorpion Bite; The Next COVID Vaccine

Categories

Archives